Form 4: EHC CFO Reports Tax-Related Stock Dispositions

Encompass Health Corp's EVP & CFO, Douglas E. Coltharp, reported the disposition of shares to cover tax withholding obligations related to restricted stock vesting.

Summary

• Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp (EHC), reported two dispositions of common stock.
• On February 19, 2026, 16,708 shares were disposed of at a price of $107.15 per share.
• On February 20, 2026, an additional 674 shares were disposed of at a price of $106.55 per share.
• These dispositions were non-discretionary, made to satisfy tax withholding obligations incurred from the vesting of restricted stock.
• Following these transactions, Mr. Coltharp directly beneficially owns 84,971 shares and indirectly owns 190,860 shares through various trusts and his spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and expected transaction related to executive compensation. The vesting of restricted stock is generally a positive event for the executive, and the subsequent tax-related sale is a standard procedure, not indicative of a change in company fundamentals or insider sentiment.

Positives

• The dispositions were for tax withholding purposes, indicating the vesting of restricted stock, which represents a positive compensation event for the executive.
• The executive retains a significant beneficial ownership of 275,831 shares (84,971 direct and 190,860 indirect), demonstrating continued alignment with shareholder interests.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that routine Form 4 filings for tax-related dispositions of restricted stock are common across all industries, particularly for executives receiving equity compensation. These transactions typically do not reflect a change in management's sentiment towards the company's future prospects but rather a standard compensation and tax event.

Comparison to Industry Standards

• These types of tax-related dispositions are standard practice for executives across publicly traded companies, such as those at HCA Healthcare (HCA) or Universal Health Services (UHS), when restricted stock units vest.
• The reported prices of $107.15 and $106.55 per share reflect the market value at the time of the transaction, which is consistent with how such transactions are executed in the industry.

Related Party Transactions

• The reported transactions are related party dealings as they involve an executive of the company. However, they are routine compensation-related transactions.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine tax-related sales, not a discretionary sale indicating a change in insider sentiment. The executive retains substantial ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing reports routine, non-discretionary sales of shares by a key executive to cover tax obligations associated with restricted stock vesting. Such transactions are common and do not typically signal a change in the company's fundamental outlook or the executive's long-term confidence. Therefore, based solely on this filing, there is no new information to warrant a change in investment posture; a "hold" recommendation is appropriate, maintaining existing positions while awaiting more substantive operational or financial news.

Keywords

Encompass Health Corp, EHC, Douglas E. Coltharp, Form 4, insider transaction, stock disposition, tax withholding, restricted stock, CFO, beneficial ownership